Clinical Trial Update: A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a phase 1/2 study of Dapansutrile plus pembrolizumab in PD-1 refractory advanced melanoma; the trial is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dapansutrile (dapansutrile)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: April Salama, M.D. | Conditions: Melanoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING